Ultimately, a deeper understanding of TNF-α signaling and its interactions with other oncogenic pathways, such as NF-κB, Wnt/β-catenin, and STAT3, will pave the way for more effective and personalized treatments for colon cancer. This evidence concerns the gene TNF and malignant colon neoplasm.